Cargando…

Retrospective study of Heparin Administration for Ischemic Stroke when there is an IV-tPA Contraindication

BACKGROUND: The majority of patients presenting with an ischemic stroke arrive after the 3-4.5 h time window allowed for intravenous tissue plasminogen activator (IV tPA) administration. Most of the literature on heparin use in acute ischemic stroke does not describe dose-adjusted intravenous unfrac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hakma, Zakaria, Stofko, Douglas L., Binning, Mandy Jo, Liebman, Kenneth, Veznedaroglu, Erol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078448/ https://www.ncbi.nlm.nih.gov/pubmed/24991465 http://dx.doi.org/10.4103/2152-7806.132032

Ejemplares similares

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?
por: Kulairi, Zain, et al.
Publicado: (2017)

Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
por: Madden, Bryan, et al.
Publicado: (2015)

tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)

Unintentional intramuscular administration of tPA/DNase for pleural infection
por: Popowicz, Natalia, et al.
Publicado: (2014)

Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke
por: Saver, Jeffrey L, et al.
Publicado: (2015)

Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA
por: Shah, Kavit, et al.
Publicado: (2021)

Variability in the Perception of Informed Consent for IV-tPA during Telestroke Consultation
por: Thomas, Lisa, et al.
Publicado: (2012)

Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19
por: Carneiro, Thiago, et al.
Publicado: (2020)

Neuroimmunomodulatory effects of transcranial laser therapy combined with intravenous tPA administration for acute cerebral ischemic injury
por: Peplow, Philip V.
Publicado: (2015)

Ischemic post-conditioning is neuroprotective even at delayed tPA administration after embolic stroke in female rats
por: Mohammadi, Mohadeseh, et al.
Publicado: (2021)

tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
por: Kim, Jong S.
Publicado: (2019)

To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019)

Intracerebral hemorrhage after IV tPA for stroke as early symptom of ANCA-associated vasculitis
por: Esfahani, Neda Zarghami, et al.
Publicado: (2017)

Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents
por: Sczepanski, Matthew, et al.
Publicado: (2018)

Cervical carotid occlusion in acute ischemic stroke: Should we give tPA?
por: Elder, Theresa A., et al.
Publicado: (2022)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

Trevo 2000: Results of a Large Real‐World Registry for Stent Retriever for Acute Ischemic Stroke
por: Binning, Mandy J., et al.
Publicado: (2018)

Double-Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro
por: Song, Shaozheng, et al.
Publicado: (2022)

Provider perceptions of barriers to the emergency use of tPA for Acute Ischemic Stroke: A qualitative study
por: Meurer, William J, et al.
Publicado: (2011)

Outcomes of Patients Requiring Blood Pressure Control Before Thrombolysis with tPA for Acute Ischemic Stroke
por: Darger, Bryan, et al.
Publicado: (2015)

Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report
por: Kim, Chris, et al.
Publicado: (2021)

Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin
por: Goncalves, Andreia, et al.
Publicado: (2022)

A modified mouse model of haemorrhagic transformation associated with tPA administration after thromboembolic stroke
por: Ye, Yang, et al.
Publicado: (2023)

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
por: Khalil, Sara, et al.
Publicado: (2023)

l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
por: Yang, Juan, et al.
Publicado: (2023)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Effect of isoflurane post-treatment on tPA-exaggerated brain injury in a rat ischemic stroke model
por: Kim, Eun Jung, et al.
Publicado: (2015)

Interferon-β modulates microglial polarization to ameliorate delayed tPA-exacerbated brain injury in ischemic stroke
por: Kuo, Ping-Chang, et al.
Publicado: (2023)

Recent tPA administration can cause pseudo‐hyperargininemia and may mimic arginase deficiency or arginine supplementation
por: Cusmano‐Ozog, Kristina P., et al.
Publicado: (2022)

Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study
por: Kim, Jong S., et al.
Publicado: (2019)

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
por: Roy, Bapti, et al.
Publicado: (2020)

NF-κB and tPA Signaling in Kidney and Other Diseases
por: White, Samantha, et al.
Publicado: (2020)

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
por: Whyte, Claire S., et al.
Publicado: (2021)

721 Defining Bleeding Characteristics in Frostbite Patients Managed with tPA
por: Murphy, Jenna E, et al.
Publicado: (2022)

Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA
por: Dong, Yi, et al.
Publicado: (2015)

Social History Matters–The Impact of Illicit Drug Use on tPA Use and In-Hospital Mortality in Acute Ischemic Stroke
por: Marx, Matthew H. M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a3mqbvib7mmltlajo7ml70i2oe